2013
DOI: 10.1016/j.brainres.2013.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
88
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 52 publications
(96 citation statements)
references
References 35 publications
7
88
1
Order By: Relevance
“…Although the mechanisms underlying the cooperation between ET-1 and VEGF have not been defined, data from the present study showing a concomitant down-regulation of ET-1-ET-B and VEGF angiogenic systems may support this hypothesis. Furthermore, Leonerd et al reported that the ETB receptor agonist, IRL-1620, has neuroprotective effects and enhances angiogenic and neurogenic remodeling following cerebral ischemia in rat model [21]. This report suggests that ET-1 plays a therapeutic role after cerebral ischemia through the activation of ET-B.…”
Section: Et Systemmentioning
confidence: 67%
See 1 more Smart Citation
“…Although the mechanisms underlying the cooperation between ET-1 and VEGF have not been defined, data from the present study showing a concomitant down-regulation of ET-1-ET-B and VEGF angiogenic systems may support this hypothesis. Furthermore, Leonerd et al reported that the ETB receptor agonist, IRL-1620, has neuroprotective effects and enhances angiogenic and neurogenic remodeling following cerebral ischemia in rat model [21]. This report suggests that ET-1 plays a therapeutic role after cerebral ischemia through the activation of ET-B.…”
Section: Et Systemmentioning
confidence: 67%
“…ET-1 is the most potent vasoconstrictor known so far [5], and it is widely known that activation of ET-B promotes the production of eNOS via Akt (also known as protein kinase B) [21]. eNOS is also produced by the VEGF pathway via KDR and Akt, so the timedependent downregulation of the mRNA expression and protein levels of eNOS in frontal cortex may contribute to the local suppression of both VEGF and ET-1 pathway.…”
Section: Et Systemmentioning
confidence: 99%
“…The power was set to 80% (β = 0.8) and the level of significance (α) used was 0.05. A sample size of 6 animals per group was determined to be sufficient to detect a 20% change in the expression of CB 1 and ET B receptors, NGF, and VEGF based on published results for the expression of these proteins [19,22,32] . Data are presented as means ± SEM.…”
Section: Discussionmentioning
confidence: 99%
“…Combined with other investigations demonstrating severe neuronal disabilities in the case of ET B deletion, it has been suggested that ET B is the primary receptor involved in CNS development [18,20,21] . Subsequently, by administration of an ET B agonist in an adult rat stroke model, Leonard et al [22] identified a relationship whereby ET B receptor expression and stimulation enhance vascular endothelial growth factor (VEGF) and neuronal growth factor (NGF) supporting neurovascular remodeling. However, pharmacological stimulation of ET B receptors during postnatal development of normal rats produced an increase in only VEGF with no change in NGF expression in the brain [19] .…”
Section: Introductionmentioning
confidence: 99%
“…8 Several studies also demonstrated that vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in development and many pathological conditions, promoted angiogenesis and neuronal remodeling after cerebral ischemia in rats. 9 A recent study showed that VEGF may reduce neural injury significantly and improve the neural function following SCIR injury. 10 It had been shown that endothelin has an effect on regulating the expression of VEGF and its receptors following cerebral ischemia and hind limbs IR.…”
Section: Introductionmentioning
confidence: 99%